Stefan Schreiber

684 total citations
9 papers, 504 citations indexed

About

Stefan Schreiber is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Stefan Schreiber has authored 9 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Stefan Schreiber's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (2 papers) and Immune Response and Inflammation (2 papers). Stefan Schreiber is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (2 papers) and Immune Response and Inflammation (2 papers). Stefan Schreiber collaborates with scholars based in Germany, United States and Canada. Stefan Schreiber's co-authors include Andreas Raedler, T Haak, Philip D. Stahl, Ulf Panzer, Takamura Muraki, Rao Fu, Richard P. MacDermott, Richard B. Johnston, Jochen Hampe and Julián Panés and has published in prestigious journals such as Gastroenterology, Diabetes Obesity and Metabolism and Journal of Crohn s and Colitis.

In The Last Decade

Stefan Schreiber

8 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Schreiber Germany 5 269 232 130 91 84 9 504
Erin Bonkowski United States 15 402 1.5× 274 1.2× 186 1.4× 154 1.7× 158 1.9× 29 747
R. Morera Italy 8 180 0.7× 124 0.5× 101 0.8× 137 1.5× 189 2.3× 12 530
Iulia Oancea Australia 13 153 0.6× 122 0.5× 97 0.7× 97 1.1× 268 3.2× 26 585
Kazutami Tamura Japan 8 99 0.4× 136 0.6× 72 0.6× 111 1.2× 113 1.3× 11 364
Nicholas A. Scott United Kingdom 13 147 0.5× 103 0.4× 58 0.4× 142 1.6× 132 1.6× 18 449
Clarke Pamela United Kingdom 8 139 0.5× 188 0.8× 47 0.4× 73 0.8× 98 1.2× 8 468
Alajos Pár Hungary 14 68 0.3× 157 0.7× 354 2.7× 87 1.0× 91 1.1× 109 700
Yoh Ishiguro Japan 12 164 0.6× 214 0.9× 92 0.7× 126 1.4× 126 1.5× 39 581
Badr Kiaf France 6 130 0.5× 346 1.5× 160 1.2× 95 1.0× 114 1.4× 7 595
Ingrid Jurickova United States 13 294 1.1× 373 1.6× 109 0.8× 105 1.2× 212 2.5× 30 757

Countries citing papers authored by Stefan Schreiber

Since Specialization
Citations

This map shows the geographic impact of Stefan Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Schreiber more than expected).

Fields of papers citing papers by Stefan Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Schreiber. The network helps show where Stefan Schreiber may publish in the future.

Co-authorship network of co-authors of Stefan Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Schreiber. A scholar is included among the top collaborators of Stefan Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Schreiber. Stefan Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Reinisch, Walter, Edward V. Loftus, Stefan Schreiber, et al.. (2025). Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis. Journal of Crohn s and Colitis. 19(4).
3.
Danese, Silvio, Julián Panés, Marla Dubinsky, et al.. (2024). Review: Risk Stratification of Patients With Ulcerative Colitis for Treatment With Tofacitinib. Crohn s & Colitis 360. 6(4). otae049–otae049. 2 indexed citations
4.
Schreiber, Stefan. (2008). Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience. Diabetes Obesity and Metabolism. 10(s2). 24–34. 3 indexed citations
6.
Hampe, Jochen, et al.. (1999). Mapping Genes for Polygenic Disorders: Considerations for Study Design in the Complex Trait of Inflammatory Bowel Disease. Human Heredity. 50(2). 91–101. 14 indexed citations
7.
Schreiber, Stefan, et al.. (1995). Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 108(5). 1434–1444. 315 indexed citations
8.
Schreiber, Stefan, et al.. (1995). Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology. 108(1). 21–33. 90 indexed citations
9.
Schreiber, Stefan, et al.. (1993). Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology. 105(1). 60–66. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026